This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs), particularly those targeting neurological and psychiatric disorders. Its structure is often incorporated into molecules designed to interact with specific receptors in the brain, such as serotonin or dopamine receptors, making it valuable in the creation of potential treatments for conditions like depression, anxiety, and schizophrenia. Additionally, its chiral nature allows for the development of enantiomerically pure drugs, which can enhance efficacy and reduce side effects. Researchers also explore its use in the preparation of compounds for preclinical studies to evaluate pharmacokinetics and pharmacodynamics.